$CPIX
CUMBERLAND PHARMACEUTICALS INC

2019 Q4 Form 10-Q Financial Statement

#000162828019014133 Filed on November 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4
Revenue $9.306M $6.935M $10.49M
YoY Change -11.27% 18.48% -9.97%
Cost Of Revenue $2.390M $1.581M $1.510M
YoY Change 58.28% 8.23% -29.77%
Gross Profit $6.920M $5.355M $600.0K
YoY Change 1053.33% 21.89% -93.68%
Gross Profit Margin 74.36% 77.21% 5.72%
Selling, General & Admin $7.180M $5.845M $2.870M
YoY Change 150.17% -14.94% -67.35%
% of Gross Profit 103.76% 109.15% 478.33%
Research & Development $2.080M $1.673M $2.940M
YoY Change -29.25% 28.08% 200.0%
% of Gross Profit 30.06% 31.24% 490.0%
Depreciation & Amortization $1.120M $1.110M $870.0K
YoY Change 28.74% 54.17% 27.94%
% of Gross Profit 16.18% 20.73% 145.0%
Operating Expenses $10.31M $7.517M $6.640M
YoY Change 55.27% -8.07% -36.15%
Operating Profit -$3.394M -$3.196M -$3.293M
YoY Change 3.07% 20.87% 264.57%
Interest Expense $20.00K $64.88K $30.00K
YoY Change -33.33% 237.92% -50.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.380M -$3.312M -$6.020M
YoY Change -43.85% 99.52% 616.67%
Income Tax -$10.00K $4.462K $0.00
% Of Pretax Income
Net Earnings -$960.7K -$1.954M -$2.220M
YoY Change -56.73% 18.91% 177.32%
Net Earnings / Revenue -10.32% -28.17% -21.17%
Basic Earnings Per Share -$0.06 -$0.13 -$0.14
Diluted Earnings Per Share -$0.06 -$0.13 -$0.14
COMMON SHARES
Basic Shares Outstanding 15.18M shares 15.37M shares 15.53M shares
Diluted Shares Outstanding 15.37M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.20M $29.24M $36.23M
YoY Change -22.16% -38.81% -27.66%
Cash & Equivalents $28.21M $26.98M $27.94M
Short-Term Investments $0.00 $2.266M $8.291M
Other Short-Term Assets $2.757M $1.992M $2.964M
YoY Change -6.96% -15.28% -14.5%
Inventory $8.871M $9.864M $9.783M
Prepaid Expenses
Receivables $7.859M $8.297M $6.460M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $50.16M $49.40M $59.12M
YoY Change -15.14% -22.36% -13.93%
LONG-TERM ASSETS
Property, Plant & Equipment $747.8K $743.8K $771.2K
YoY Change -3.04% 37.99% 45.82%
Goodwill $882.0K $882.0K $784.0K
YoY Change 12.5%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.299M $6.329M $2.531M
YoY Change 30.32% 125.28% 1.79%
Total Long-Term Assets $54.39M $54.37M $53.58M
YoY Change 1.51% 128.38% 118.26%
TOTAL ASSETS
Total Short-Term Assets $50.16M $49.40M $59.12M
Total Long-Term Assets $54.39M $54.37M $53.58M
Total Assets $104.5M $103.8M $112.7M
YoY Change -7.23% 18.68% 20.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.994M $8.227M $8.211M
YoY Change 21.71% -2.61% -8.57%
Accrued Expenses $11.08M $900.0K $16.04M
YoY Change -30.91% 84.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.15M $21.05M $27.80M
YoY Change -13.14% 35.67% 57.13%
LONG-TERM LIABILITIES
Long-Term Debt $18.50M $20.00M $20.00M
YoY Change -7.5% 66.67% 104.08%
Other Long-Term Liabilities $8.737M $11.00M $9.319M
YoY Change -6.24% 450.0% 413.18%
Total Long-Term Liabilities $8.737M $31.00M $9.319M
YoY Change -6.24% 121.43% 413.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.15M $21.05M $27.80M
Total Long-Term Liabilities $8.737M $31.00M $9.319M
Total Liabilities $53.46M $52.06M $57.12M
YoY Change -6.41% 76.55% 94.89%
SHAREHOLDERS EQUITY
Retained Earnings $1.208M $2.169M $4.746M
YoY Change -74.54% -68.86% -59.47%
Common Stock $49.91M $49.56M $51.10M
YoY Change -2.32% -3.26% -2.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $51.12M $51.73M $55.84M
YoY Change
Total Liabilities & Shareholders Equity $104.5M $103.8M $112.7M
YoY Change -7.23% 18.68% 20.87%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4
OPERATING ACTIVITIES
Net Income -$960.7K -$1.954M -$2.220M
YoY Change -56.73% 18.91% 177.32%
Depreciation, Depletion And Amortization $1.120M $1.110M $870.0K
YoY Change 28.74% 54.17% 27.94%
Cash From Operating Activities $860.0K $740.0K $3.720M
YoY Change -76.88% -145.12% -908.7%
INVESTING ACTIVITIES
Capital Expenditures -$360.0K -$180.0K -$2.700M
YoY Change -86.67% -79.07% 462.5%
Acquisitions
YoY Change
Other Investing Activities $2.260M $7.120M -$18.72M
YoY Change -112.07% 34.85% -653.85%
Cash From Investing Activities $1.910M $6.940M -$21.41M
YoY Change -108.92% 56.66% -835.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.530M -1.640M 7.370M
YoY Change -120.76% 281.4% 684.04%
NET CHANGE
Cash From Operating Activities 860.0K 740.0K 3.720M
Cash From Investing Activities 1.910M 6.940M -21.41M
Cash From Financing Activities -1.530M -1.640M 7.370M
Net Change In Cash 1.240M 6.040M -10.32M
YoY Change -112.02% 155.93% -404.42%
FREE CASH FLOW
Cash From Operating Activities $860.0K $740.0K $3.720M
Capital Expenditures -$360.0K -$180.0K -$2.700M
Free Cash Flow $1.220M $920.0K $6.420M
YoY Change -81.0% -217.95% 32000.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001087294
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33637
dei Entity Registrant Name
EntityRegistrantName
Cumberland Pharmaceuticals Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1765329
dei Entity Address Address Line1
EntityAddressAddressLine1
2525 West End Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 950
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37203
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
255-0068
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2963806 USD
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock, no par value
dei Trading Symbol
TradingSymbol
CPIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15183943 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26978424 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27938960 USD
CY2019Q3 us-gaap Marketable Securities
MarketableSecurities
2265839 USD
CY2018Q4 us-gaap Marketable Securities
MarketableSecurities
8290679 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8296672 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7844249 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
9864240 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
12078343 USD
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1992409 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
49397584 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
59116037 USD
CY2019Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
15329920 USD
CY2018Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
15749000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
743801 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
771213 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31040213 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
33655099 USD
CY2019Q3 us-gaap Goodwill
Goodwill
882000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
784000 USD
CY2019Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
43605 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
87210 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6328777 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2531309 USD
CY2019Q3 us-gaap Assets
Assets
103765900 USD
CY2018Q4 us-gaap Assets
Assets
112693868 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8226609 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11093297 USD
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12826341 USD
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16710927 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
21052950 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27804224 USD
CY2019Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
20000000 USD
CY2018Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
20000000 USD
CY2019Q3 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
11006022 USD
CY2018Q4 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
9319143 USD
CY2019Q3 us-gaap Liabilities
Liabilities
52058972 USD
CY2018Q4 us-gaap Liabilities
Liabilities
57123367 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15231278 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15231278 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15481497 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15481497 shares
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
49563807 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
51098613 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2169101 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4746154 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
51732908 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
55844767 USD
CY2019Q3 us-gaap Minority Interest
MinorityInterest
-25980 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
-274266 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51706928 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55570501 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103765900 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
112693868 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10371918 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8492530 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33855265 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27243859 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1921875 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1460463 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5933807 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4511743 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5562443 USD
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4803112 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15836077 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14549873 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1278013 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1306055 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4003980 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4631384 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2422886 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2067981 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7621858 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6732485 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1033786 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
661802 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3085139 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1946457 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
12219003 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
10299413 USD
us-gaap Costs And Expenses
CostsAndExpenses
36480861 USD
us-gaap Costs And Expenses
CostsAndExpenses
32371942 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1847085 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1806883 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2625596 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5128083 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
-50511 USD
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
166220 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
195915 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
398420 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
64877 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
19199 USD
us-gaap Interest Expense
InterestExpense
216988 USD
us-gaap Interest Expense
InterestExpense
59520 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1962473 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1659862 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2646669 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4789183 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4462 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4159 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-72504 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12477 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1966935 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-1664021 USD
us-gaap Profit Loss
ProfitLoss
-2574165 USD
us-gaap Profit Loss
ProfitLoss
-4801660 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13267 USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-20977 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2888 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-58689 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1953668 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1643044 USD
us-gaap Net Income Loss
NetIncomeLoss
-2577053 USD
us-gaap Net Income Loss
NetIncomeLoss
-4742971 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15368027 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15573108 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15454159 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15645230 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15368027 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15573108 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15454159 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15645230 shares
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1953668 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1643044 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2577053 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4742971 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
13267 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
20977 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2888 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
58689 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1966935 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1664021 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2574165 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4801660 USD
us-gaap Profit Loss
ProfitLoss
-2574165 USD
us-gaap Profit Loss
ProfitLoss
-4801660 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3278958 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2108051 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43605 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1107817 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1005239 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
681577 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36292 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
44117 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
34303 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
131652 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-547577 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1339974 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2214103 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-311419 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-195529 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-966817 USD
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
-1726832 USD
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
-1595243 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-207648 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
142486 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2199356 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-610452 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
166407 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
171731 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9627191 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
20851951 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15686334 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
16122376 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
5000000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
498003 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1411710 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
394733 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6313016 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
56000000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
36000000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
56000000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
33800000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200909 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
248108 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
52500 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
908347 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2593778 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2382968 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3554625 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-230167 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-960536 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7153635 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27938960 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45412868 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26978424 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38259233 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3629320 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
53688717 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1000000 USD
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 USD
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-800000 USD
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
0 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
148000 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
63921601 USD
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200909 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
339209 USD
CY2018Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1195225 USD
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-2392189 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60874305 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60874305 USD
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
326100 USD
CY2018Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
784505 USD
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-745450 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59670450 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
59670450 USD
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
339930 USD
CY2018Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
401747 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-1664021 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57944612 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55570501 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
364434 USD
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
703790 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-40418 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55190727 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55190727 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
396548 USD
CY2019Q2 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-800000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
531746 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-566812 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
53688717 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
346835 USD
CY2019Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
1000000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1361689 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1966935 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51706928 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration: underline;">Use of Estimates</span></div><div style="text-align:justify;margin-top:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:400;line-height:120%;">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns (2) the allowances for obsolescent or unmarketable inventory (3) assumptions used in estimating acquisition date fair value of assets acquired in business combinations and (4) valuation of contingent consideration liability associated with business combinations.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2019Q3 us-gaap Trading Securities
TradingSecurities
2265839 USD
CY2018Q4 us-gaap Trading Securities
TradingSecurities
8290679 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1953668 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1643044 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15368027 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15573108 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15368027 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15573108 shares
us-gaap Net Income Loss
NetIncomeLoss
-2577053 USD
us-gaap Net Income Loss
NetIncomeLoss
-4742971 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15454159 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15645230 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15454159 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15645230 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3600 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18325 shares
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8511887 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
897506 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10371918 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8492530 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33855265 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27243859 USD
CY2019Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
500000 USD
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000 USD
CY2019Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19176660 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
18378450 USD
CY2019Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
723324 USD
CY2018Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
937006 USD
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5294176 USD
CY2019Q3 us-gaap Inventory Gross
InventoryGross
25194160 USD
CY2018Q4 us-gaap Inventory Gross
InventoryGross
27827343 USD
CY2019Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
15329920 USD
CY2018Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
15749000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
9864240 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
12078343 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3600000 USD
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3800000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0742
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3047283 USD
CY2019Q3 cpix Lease Asset
LeaseAsset
3047283 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2315761 USD
CY2019Q3 cpix Lease Liability
LeaseLiability
3213267 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
282646 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1120067 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1144889 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1019313 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
92477 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3659392 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
446125 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3213267 USD
CY2010Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2016Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2018Q3 cpix Sale Of Stock Number Of Shares Sold
SaleOfStockNumberOfSharesSold
117729 shares
CY2017Q4 cpix Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities
StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
100000000 USD
CY2019Q2 cpix Subsidiary Investment Conversion Of Intercompany Loans Payable
SubsidiaryInvestmentConversionOfIntercompanyLoansPayable
700000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000 USD
CY2019Q2 cpix Subsidiary Investment Cash Contribution
SubsidiaryInvestmentCashContribution
300000 USD
CY2019Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
44100000 USD
CY2019Q1 cpix Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
2300000 USD

Files In Submission

Name View Source Status
0001628280-19-014133-index-headers.html Edgar Link pending
0001628280-19-014133-index.html Edgar Link pending
0001628280-19-014133.txt Edgar Link pending
0001628280-19-014133-xbrl.zip Edgar Link pending
a2019q3-exhibit311.htm Edgar Link pending
a2019q3-exhibit312.htm Edgar Link pending
a2019q3-exhibit321.htm Edgar Link pending
cpix-20190930.htm Edgar Link pending
cpix-20190930.xsd Edgar Link pending
cpix-20190930_cal.xml Edgar Link unprocessable
cpix-20190930_def.xml Edgar Link unprocessable
cpix-20190930_htm.xml Edgar Link completed
cpix-20190930_lab.xml Edgar Link unprocessable
cpix-20190930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending